Tassinari Valentina, Cerboni Cristina, Soriani Alessandra
Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Biology (Basel). 2022 Apr 8;11(4):568. doi: 10.3390/biology11040568.
A-to-I editing is a post-transcriptional mechanism affecting coding and non-coding dsRNAs, catalyzed by the adenosine deaminases acting on the RNA (ADAR) family of enzymes. A-to-I modifications of endogenous dsRNA (mainly derived from repetitive elements) prevent their recognition by cellular dsRNA sensors, thus avoiding the induction of antiviral signaling and uncontrolled IFN-I production. This process, mediated by ADAR1 activity, ensures the activation of an innate immune response against foreign (non-self) but not self nucleic acids. As a consequence, ADAR1 mutations or its de-regulated activity promote the development of autoimmune diseases and strongly impact cell growth, also leading to cancer. Moreover, the excessive inflammation promoted by ablation also impacts T and B cell maturation, as well as the development of dendritic cell subsets, revealing a new role of ADAR1 in the homeostasis of the immune system.
A-to-I编辑是一种影响编码和非编码双链RNA的转录后机制,由作用于RNA的腺苷脱氨酶(ADAR)家族酶催化。内源性双链RNA(主要来源于重复元件)的A-to-I修饰可防止细胞双链RNA传感器对其进行识别,从而避免诱导抗病毒信号和不受控制的I型干扰素产生。这一由ADAR1活性介导的过程确保了针对外来(非自身)而非自身核酸的先天性免疫反应的激活。因此,ADAR1突变或其活性失调会促进自身免疫性疾病的发展,并对细胞生长产生强烈影响,还会导致癌症。此外,基因敲除所引发的过度炎症也会影响T细胞和B细胞的成熟,以及树突状细胞亚群的发育,揭示了ADAR1在免疫系统稳态中的新作用。